Department of Hepatology and Gastroenterology, Ghent University Hospital, Ghent, Belgium.
Liver Transpl. 2013 Jun;19(6):602-10. doi: 10.1002/lt.23649. Epub 2013 May 3.
Portopulmonary hypertension (POPH), a complication of chronic liver disease, may be a contraindication to liver transplantation (LT) because of the elevated risk of peritransplant and posttransplant morbidity and mortality. Because POPH is frequently asymptomatic, screening with echocardiography is recommended. The only reliable technique, however, for diagnosing POPH is right heart catheterization (RHC). The aims of this study were to evaluate the current estimated systolic pulmonary artery pressure (sPAP) cutoff value of 30 mm Hg and to determine a better cutoff value. One hundred fifty-two patients underwent pretransplant echocardiography between January 2005 and December 2010. These echocardiographic results were compared with pulmonary artery pressures measured during the pretransplant workup or at the beginning of the transplantation procedure (both by catheterization). With a cutoff value of 30 mm Hg, 74 of the 152 patients met the criteria for POPH on echocardiography, although the diagnosis was confirmed in only 7 patients during catheterization; this resulted in a specificity of 54%. It would have been more accurate to use a cutoff value of 38 mm Hg, which had a maximal specificity of 82% and, at the same time, guaranteed a sensitivity and negative predictive value of 100%. With the incorporation of the presence or absence of right ventricular dilatation, the specificity even increased to 93% for this new cutoff value. In conclusion, the prevalence of POPH was 4.6% among LT candidates in this study. We can recommend that LT candidates with an sPAP > 38 mm Hg should be referred for RHC. With the cutoff value increased from 30 to 38 mm Hg, the number of patients undergoing invasive RHC during their evaluation could be safely reduced.
肝移植(LT)的禁忌证之一是门静脉高压症(POPH),这是一种慢性肝病的并发症,因为围手术期和术后发病率和死亡率升高。由于 POPH 通常无症状,因此建议进行超声心动图筛查。然而,诊断 POPH 的唯一可靠技术是右心导管检查(RHC)。本研究的目的是评估目前估计的收缩期肺动脉压(sPAP)截断值 30mmHg,并确定更好的截断值。2005 年 1 月至 2010 年 12 月期间,152 例患者接受了 LT 前的超声心动图检查。将这些超声心动图结果与 LT 前检查期间或移植手术开始时(均通过导管测量)的肺动脉压进行比较。以 30mmHg 为截断值,152 例患者中有 74 例在超声心动图上符合 POPH 标准,尽管仅在 7 例患者的导管检查中得到确认;这导致特异性为 54%。如果使用 38mmHg 的截断值,特异性将达到 82%,同时保证 100%的敏感性和阴性预测值,这将更加准确。同时,结合右心室扩张的有无,特异性甚至提高到新截断值的 93%。总之,在这项研究中,LT 候选者中 POPH 的患病率为 4.6%。我们可以建议,sPAP>38mmHg 的 LT 候选者应进行 RHC。将截断值从 30mmHg 增加到 38mmHg 可以安全地减少评估期间进行有创 RHC 的患者数量。